AMILI, a Singapore-based gut microbiome company, announced raising $10.5 million in Series A funding anchored by Vulcan Capital, the investment arm of the late Microsoft Corp co-founder Paul Allen.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
